TERM ID="NYU_TERM_1" STRING="Economic Aspects" FREQUENCY=1 START=765 END=781 LEMMA="ECONOMIC ASPECT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_2" STRING="Economic Aspects of Osteoporosis" FREQUENCY=1 START=765 END=797 LEMMA="OSTEOPOROSI ECONOMIC ASPECT" LEMMA_FREQUENCY=1 HEAD_TERM="Economic Aspects" HEAD_LEMMA="ECONOMIC ASPECT"
TERM ID="NYU_TERM_3" STRING="Osteoarthritis" FREQUENCY=1 START=802 END=816 LEMMA="OSTEOARTHRITI" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_4" STRING="Osteoporosis" FREQUENCY=1 START=785 END=797 LEMMA="OSTEOPOROSI" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_5" STRING="Potential treatments" FREQUENCY=1 START=325 END=345 LEMMA="POTENTIAL TREATMENT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_6" STRING="Recommendations" FREQUENCY=1 START=0 END=15 LEMMA="RECOMMENDATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_7" STRING="Relevant parallels" FREQUENCY=1 START=938 END=956 LEMMA="RELEVANT PARALLEL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_8" STRING="case-finding decision tree" FREQUENCY=1 START=1108 END=1134 LEMMA="CASE-FINDING DECISION TREE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_9" STRING="clinical assessment" FREQUENCY=1 START=1036 END=1055 LEMMA="CLINICAL ASSESSMENT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_10" STRING="clinical assessment of pharmaceutical treatments" FREQUENCY=1 START=1036 END=1084 LEMMA="PHARMACEUTICAL TREATMENT CLINICAL ASSESSMENT" LEMMA_FREQUENCY=1 HEAD_TERM="clinical assessment" HEAD_LEMMA="CLINICAL ASSESSMENT"
TERM ID="NYU_TERM_11" STRING="clinical experience" FREQUENCY=1 START=891 END=910 LEMMA="CLINICAL EXPERIENCE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_12" STRING="clinical trials" FREQUENCY=2 START=35 END=50 LEMMA="CLINICAL TRIAL" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_13" STRING="clinical trials" FREQUENCY=2 START=1569 END=1584 LEMMA="CLINICAL TRIAL" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_14" STRING="clinical trials of sarcopenia" FREQUENCY=1 START=1569 END=1598 LEMMA="SARCOPENIA CLINICAL TRIAL" LEMMA_FREQUENCY=1 HEAD_TERM="clinical trials" HEAD_LEMMA="CLINICAL TRIAL"
TERM ID="NYU_TERM_15" STRING="economic burden" FREQUENCY=1 START=308 END=323 LEMMA="ECONOMIC BURDEN" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_16" STRING="endpoints" FREQUENCY=1 START=1449 END=1458 LEMMA="ENDPOINT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_17" STRING="establishment" FREQUENCY=1 START=1515 END=1528 LEMMA="ESTABLISHMENT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_18" STRING="guideline development" FREQUENCY=1 START=915 END=936 LEMMA="GUIDELINE DEVELOPMENT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_19" STRING="investigation" FREQUENCY=1 START=1347 END=1360 LEMMA="INVESTIGATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_20" STRING="mobility disability" FREQUENCY=1 START=182 END=201 LEMMA="MOBILITY DISABILITY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_21" STRING="multidisciplinary expert" FREQUENCY=1 START=674 END=698 LEMMA="MULTIDISCIPLINARY EXPERT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_22" STRING="multidisciplinary expert working group" FREQUENCY=1 START=674 END=712 LEMMA="WORKING GROUP MULTIDISCIPLINARY EXPERT" LEMMA_FREQUENCY=1 HEAD_TERM="working group" HEAD_LEMMA="WORKING GROUP"
TERM ID="NYU_TERM_23" STRING="muscle condition" FREQUENCY=1 START=121 END=137 LEMMA="MUSCLE CONDITION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_24" STRING="objective" FREQUENCY=1 START=462 END=471 LEMMA="OBJECTIVE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_25" STRING="osteoporosis" FREQUENCY=1 START=1006 END=1018 LEMMA="OSTEOPOROSI" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_26" STRING="pharmaceutical treatments" FREQUENCY=1 START=1059 END=1084 LEMMA="PHARMACEUTICAL TREATMENT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_27" STRING="position paper" FREQUENCY=1 START=480 END=494 LEMMA="POSITION PAPER" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_28" STRING="potential endpoints" FREQUENCY=1 START=528 END=547 LEMMA="POTENTIAL ENDPOINT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_29" STRING="prevalence estimations" FREQUENCY=1 START=1183 END=1205 LEMMA="PREVALENCE ESTIMATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_30" STRING="project development" FREQUENCY=1 START=1415 END=1434 LEMMA="PROJECT DEVELOPMENT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_31" STRING="regulatory communities" FREQUENCY=1 START=648 END=670 LEMMA="REGULATORY COMMUNITY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_32" STRING="regulatory studies" FREQUENCY=2 START=403 END=421 LEMMA="REGULATORY STUDY" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_33" STRING="regulatory studies" FREQUENCY=2 START=1285 END=1303 LEMMA="REGULATORY STUDY" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_34" STRING="sarcopenia" FREQUENCY=3 START=446 END=456 LEMMA="SARCOPENIA" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_35" STRING="sarcopenia" FREQUENCY=3 START=1588 END=1598 LEMMA="SARCOPENIA" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_36" STRING="sarcopenia" FREQUENCY=3 START=1684 END=1694 LEMMA="SARCOPENIA" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_37" STRING="sarcopenia Sarcopenia" FREQUENCY=1 START=81 END=102 LEMMA="SARCOPENIA SARCOPENIA" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_38" STRING="sarcopenia prevention" FREQUENCY=1 START=1362 END=1383 LEMMA="SARCOPENIA PREVENTION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_39" STRING="selection criteria" FREQUENCY=1 START=1250 END=1268 LEMMA="SELECTION CRITERION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_40" STRING="target population definitions" FREQUENCY=1 START=552 END=581 LEMMA="TARGET POPULATION DEFINITION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_41" STRING="therapeutic treatments" FREQUENCY=1 START=1657 END=1679 LEMMA="THERAPEUTIC TREATMENT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_42" STRING="therapeutic treatments for sarcopenia" FREQUENCY=1 START=1657 END=1694 LEMMA="SARCOPENIA THERAPEUTIC TREATMENT" LEMMA_FREQUENCY=1 HEAD_TERM="therapeutic treatments" HEAD_LEMMA="THERAPEUTIC TREATMENT"
TERM ID="NYU_TERM_43" STRING="threshold values" FREQUENCY=1 START=1228 END=1244 LEMMA="THRESHOLD VALUE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_44" STRING="working group" FREQUENCY=1 START=699 END=712 LEMMA="WORKING GROUP" LEMMA_FREQUENCY=1
